Bronchoscopic Re-biopsy for Mutational Analysis of Non-small Cell Lung Cancer

被引：0
|
作者：
Keisuke Kirita
Takehiro Izumo
Yuji Matsumoto
Yoshihisa Hiraishi
Takaaki Tsuchida
机构：
[1] National Cancer Center Hospital,Department of Endoscopy, Respiratory Endoscopy Division
[2] National Cancer Center Hospital East,Division of Thoracic Oncology
来源：
Lung | 2016年 / 194卷
关键词：
Bronchoscopy; EBUS; Driver oncogene mutation; Lung cancer; Re-biopsy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：371 / 378
页数：7
相关论文
共 50 条
  • [21] Liquid Biopsy in Non-Small Cell Lung Cancer
    Molina-Vila, Miguel A.
    Mayo-de-las-Casas, Clara
    Gimenez-Capitan, Ana
    Jordana-Ariza, Nuria
    Garzon, Monica
    Balada, Ariadna
    Villatoro, Sergi
    Teixido, Cristina
    Garcia-Pelaez, Beatriz
    Aguado, Cristina
    Jose Catalan, Maria
    Campos, Raquel
    Perez-Rosado, Ana
    Bertran-Alamillo, Jordi
    Martinez-Bueno, Alejandro
    Gil, Maria-de-los-Lianos
    Gonzalez-Cao, Maria
    Gonzalez, Xavier
    Morales-Espinosa, Daniela
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    FRONTIERS IN MEDICINE, 2016, 3
  • [22] MODALITY OF TISSUE BIOPSY AND MUTATIONAL ANALYSIS IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER: A SINGLE CENTRE AUDIT
    Moore, S.
    Murphy, M.
    Hukins, C.
    Loff, K.
    RESPIROLOGY, 2019, 24 : 160 - 160
  • [23] The need of re-biopsy: Increase in PD-L1 expression from initial stage to recurrence of non-small cell lung cancer
    Lacour, M.
    Lee, S. Y.
    Rulle, U.
    Soltermann, A.
    Rushing, E. J.
    Soldini, D.
    Hiltbrunner, S.
    Weder, W.
    Curioni-Fontecedro, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 512 - 512
  • [24] Re-biopsy for advanced non-small cell lung cancer after EGFR tyrosine kinase inhibitor therapy: CT characteristics of patients with T790M mutation and the use of various re-biopsy procedures
    Koo, H. J.
    Kim, M. Y.
    Choi, C-M.
    Lee, J. C.
    Park, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice
    Katsuyuki Hotta
    Kiichiro Ninomiya
    Eiki Ichihara
    Katsuyuki Kiura
    International Journal of Clinical Oncology, 2019, 24 : 41 - 45
  • [26] Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice
    Hotta, Katsuyuki
    Ninomiya, Kiichiro
    Ichihara, Eiki
    Kiura, Katsuyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (01) : 41 - 45
  • [27] Re-biopsy patterns among non- small cell lung cancer patients(pats) in Japan: a retrospective study
    Yoshida, Tatsuya
    Satouchi, Miyako
    Kurata, Takayasu
    Nosaki, Kaname
    Seto, Takashi
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
    van den Heuvel, Guus R. M.
    Kroeze, Leonie I.
    Ligtenberg, Marjolijn J. L.
    Grunberg, Katrien
    Jansen, Erik A. M.
    von Rhein, Daniel
    de Voer, Richarda M.
    van den Heuvel, Michel M.
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [29] Digital Core Needle-Biopsy to Assess PD-L1 Expression in Non-Small Cell Lung Cancer: Optimal Sampling and Need for Re-Biopsy
    Haragan, A.
    Field, J.
    Davies, M.
    Escriu, C.
    Gruver, A.
    Gosney, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S534 - S535
  • [30] Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
    Guus R. M. van den Heuvel
    Leonie I. Kroeze
    Marjolijn J. L. Ligtenberg
    Katrien Grünberg
    Erik A. M. Jansen
    Daniel von Rhein
    Richarda M. de Voer
    Michel M. van den Heuvel
    Respiratory Research, 22
12345